PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9687511-5	1998	Moreover, suppression of PKCbetaII activity in BCR/ABL-expressing cells by treatment with the PKCbetaII inhibitor CGP53353, or by expression of a dominant-negative PKCbetaII, markedly impaired the ability of FUS to bind DNA.	4,5-dianilinophthalimide	114-122	c-abl oncogene 1, non-receptor tyrosine kinase	Mus musculus	51-54